🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted measures to tackle cost of living challenges" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a collective task of both the administration and the central bank.

The UK's price growth is expected to be the most elevated among the Group of Seven developed nations this calendar year and next.

Possible Energy Cost Interventions

It is understood the administration could take action to bring down energy bills, for instance by slashing the present 5% level of VAT applied on energy.

Another possibility is to reduce some of the government charges presently included in bills.

Budgetary Limitations and Analyst Predictions

The government will receive the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for these actions.

The view from most economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to fulfill her voluntary debt limits.

Previously on Thursday, analysis showed there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of forecasts.

"There's a collective responsibility between the Bank of England and the administration to continue tackling some of the sources of price increases," the Chancellor informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Commitments and International Concerns

While much of the focus has been on probable tax rises, the Treasury chief said the latest information from the fiscal watchdog had not altered her vow to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with growing international and trade issues for the fiscal tax moves, probably to be focused on those "wealthiest."

Global Trade Tensions

Addressing concerns about the UK's commercial links with China she said: "Our security interests invariably are paramount."

Last week's statement by China to strengthen export controls on critical minerals and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an additional 100% import tax on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The American finance chief called the Chinese action "economic coercion" and "a international production power grab."

Asked about considering the American proposal to join its dispute with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and called on the Chinese government "not to put up barriers and restrict access."

She said the action was "bad for the international commerce and generates additional challenges."

"I believe there are sectors where we should confront China, but there are also significant opportunities to sell into Chinese markets, including banking sector and other areas of the economy. We've got to get that balance right."

The chancellor also stated she was cooperating with international partners "on our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Pricing and Funding

Reeves also recognized that the cost the National Health Service pays for medicines could go up as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the UK, with some blaming the insufficient payments they are receiving.

Last month, the government science advisor said the cost the NHS spends on drugs would have to increase to stop companies and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen because of the pricing regime, that clinical trials, new drugs have not been available in the United Kingdom in the way that they are in other continental states."

"We want to ensure that individuals receiving treatment from the National Health Service are able to receive the best life-saving medicines in the globe. And so we are examining this situation, and... looking to attract more investment into Britain."